Nexesta Fe 28 Day
- RxCUI
- 1869047
- RxNorm name
- Nexesta Fe 28 Day
- Display name
- Nexesta Fe 28 Day
- Full name
- Nexesta Fe 28 Day
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nexesta Fe | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Aurobindo Pharma Limited | 6eb8f7b6-4b8e-4bad-800a-b2f3b36c3413 | 2021-12-04 | Boxed warning, Warnings, Adverse reactions | 1869047 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6eb8f7b6-4b8e-4bad-800a-b2f3b36c3413 | {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Nexesta Fe 28 Day] [BPCK] · Nexesta Fe 28 Day [PSN] · Nexesta Fe 28 Day [SY] | 3 | 6 | These highlights do not include all the information needed to use NEXESTA TM Fe safely and effectively. See Full Prescribing Information for NEXESTA Fe. NEXESTA Fe (norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable)) for oral use Initial U.S. Approval: 1975 | 20211204 |